GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Guanhao Biotech Co Ltd (SZSE:300238) » Definitions » EV-to-EBITDA

Guanhao Biotech Co (SZSE:300238) EV-to-EBITDA : 103.95 (As of May. 27, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Guanhao Biotech Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Guanhao Biotech Co's enterprise value is ¥2,719.3 Mil. Guanhao Biotech Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ¥26.2 Mil. Therefore, Guanhao Biotech Co's EV-to-EBITDA for today is 103.95.

The historical rank and industry rank for Guanhao Biotech Co's EV-to-EBITDA or its related term are showing as below:

SZSE:300238' s EV-to-EBITDA Range Over the Past 10 Years
Min: -247.67   Med: 86.55   Max: 383.31
Current: 103.95

During the past 13 years, the highest EV-to-EBITDA of Guanhao Biotech Co was 383.31. The lowest was -247.67. And the median was 86.55.

SZSE:300238's EV-to-EBITDA is ranked worse than
92.67% of 450 companies
in the Biotechnology industry
Industry Median: 9.57 vs SZSE:300238: 103.95

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-27), Guanhao Biotech Co's stock price is ¥10.22. Guanhao Biotech Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.090. Therefore, Guanhao Biotech Co's PE Ratio for today is 113.56.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Guanhao Biotech Co EV-to-EBITDA Historical Data

The historical data trend for Guanhao Biotech Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guanhao Biotech Co EV-to-EBITDA Chart

Guanhao Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.85 77.06 37.98 -10.27 55.36

Guanhao Biotech Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.02 -203.90 -232.12 55.36 105.69

Competitive Comparison of Guanhao Biotech Co's EV-to-EBITDA

For the Biotechnology subindustry, Guanhao Biotech Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guanhao Biotech Co's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Guanhao Biotech Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Guanhao Biotech Co's EV-to-EBITDA falls into.



Guanhao Biotech Co EV-to-EBITDA Calculation

Guanhao Biotech Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=2719.335/26.159
=103.95

Guanhao Biotech Co's current Enterprise Value is ¥2,719.3 Mil.
Guanhao Biotech Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥26.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guanhao Biotech Co  (SZSE:300238) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Guanhao Biotech Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=10.22/0.090
=113.56

Guanhao Biotech Co's share price for today is ¥10.22.
Guanhao Biotech Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.090.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Guanhao Biotech Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Guanhao Biotech Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Guanhao Biotech Co (SZSE:300238) Business Description

Traded in Other Exchanges
N/A
Address
No.12 Yuyan Road, Luogang District, Guangdong, Guangzhou, CHN, 510530
Guanhao Biotech Co Ltd is a China-based biotech company. It develops, manufactures and markets life and health-related products, with focus on regenerative medicines for the treatment of damaged tissue and organs. Its products include NormalGEN dura repair patch, GrandNeuro (Type B) dura repair patch, ThromalGEN (Type P) surgical patch, Guanhao-ACI, among others.
Executives
Liu De Wang Directors, executives
Zhao Jun Hui Directors, executives
Yang Guo Sheng Supervisors
Zhu Wei Ping Director
Hu Jun Securities Affairs Representative
Jia Bao Rong Executives
Jia Jun Chao Executives
Di Pu Director
Zhuo Fu Min Director
Guo Xiao Ming Executives
Zhang Hong Tao Executives
Zhao Wen Jie Executives
Guan Xin Director

Guanhao Biotech Co (SZSE:300238) Headlines

No Headlines